Hedge Fund - Lynx1 Capital Management
Stoke Therapeutics Inc. (STOK)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $171,544,353 | 34.73% | 5,404,674 | $30.06 |
| 2 | 2025 - Q3 (2025-09-30) | $109,881,253 | 22.37% | 5,404,674 | $17.13 |
| 3 | 2025 - Q2 (2025-06-30) | $61,343,050 | 17.72% | 5,404,674 | $9.49 |
| 4 | 2025 - Q1 (2025-03-31) | $35,191,328 | 12.6% | 5,291,929 | $9.32 |
| 5 | 2024 - Q4 (2024-12-31) | $57,214,717 | 21.45% | 5,187,191 | $12.29 |
| 6 | 2024 - Q3 (2024-09-30) | $63,750,577 | 22.58% | 5,187,191 | $14.17 |
| 7 | 2024 - Q2 (2024-06-30) | $70,051,931 | 25.31% | 5,185,191 | $13.50 |
| 8 | 2024 - Q1 (2024-03-31) | $49,907,070 | 12.85% | 3,696,820 | $6.06 |
| 9 | 2023 - Q4 (2023-12-31) | $15,553,389 | 6.11% | 2,956,918 | $4.27 |
| 10 | 2023 - Q3 (2023-09-30) | $6,738,007 | 4.45% | 1,710,154 | $6.58 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center